🇯🇵 Opalmon in Japan

Opalmon (LIMAPROST) regulatory status in Japan.

Marketing authorisation

PMDA

  • Status: approved

Opalmon in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Cardiovascular approved in Japan

Frequently asked questions

Is Opalmon approved in Japan?

Yes. PMDA has authorised it.

Who is the marketing authorisation holder for Opalmon in Japan?

Marketing authorisation holder not available in our data.